Industry: Chemical & Material
Published Date: 2026-03-06
Pages: 137 Pages
Report ld: 6019417
Request Sample
Customized Report
Ursodeoxycholic Acid API Market Size(US$)

CAGR 2026-2032
8.6%
Market Size,2032
USD 1,112
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Ursodeoxycholic Acid API market was valued at US$ 620 million in 2025 and is anticipated to reach US$ 1112 million by 2032, witnessing a CAGR of 8.6% during the forecast period 2026-2032.
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. In addition, the CAS number is 128-13-2.
The growing prevalence of liver diseases, such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and certain forms of liver cirrhosis, serves as a significant driver for the Ursodeoxycholic Acid (UDCA) API market. As more individuals are diagnosed with these conditions due to improved medical awareness and diagnostic techniques, the demand for effective treatments like UDCA increases. UDCA has demonstrated efficacy in managing and alleviating symptoms of these liver diseases, positioning it as a valuable therapeutic option. The rising global burden of liver disorders, often associated with factors like aging and lifestyle changes, provides a sustained demand for UDCA API as a key component in manufacturing medications to address these conditions.
However, the UDCA API market faces several challenges, with regulatory hurdles and price pressures being significant constraints. The stringent approval requirements and the need for high-quality production standards in API manufacturing can delay the market entry of new players and increase operational costs. Furthermore, with the increasing production of generic UDCA products, competition has intensified, leading to a decrease in profit margins for manufacturers of branded UDCA drugs. Another challenge is the limited scope of UDCA applications, as the drug is effective primarily for a specific set of liver conditions, limiting its broader market appeal. Additionally, supply chain disruptions and raw material price fluctuations for manufacturing UDCA can affect the availability and cost-effectiveness of APIs, further complicating market dynamics.
Global key players of Ursodeoxycholic Acid API include ICE, Daewoong Chemical, PharmaZell GmbH and Zhongshan Bailing, etc. The top five players hold a share about 81%.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Ursodeoxycholic Acid API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ursodeoxycholic Acid API.
The Ursodeoxycholic Acid API market size, estimations, and forecasts are provided in terms of sales quantity (Tons) and revenue ($ millions), considering 2025 as the base year, with history and forecast data for the period from 2021 to 2032. This report segments the global Ursodeoxycholic Acid API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ursodeoxycholic Acid API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Ursodeoxycholic Acid API Market Overview
1.1 Product Definition
1.2 Ursodeoxycholic Acid API Market by Type
1.2.1 Global Ursodeoxycholic Acid API Market Value by Type (2021-2032)
1.2.2 Chemical Method
1.2.3 Enzyme Method
1.3 Ursodeoxycholic Acid API Market by Diseases
1.3.1 Global Ursodeoxycholic Acid API Market Value by Diseases (2021-2032)
1.3.2 Bile Disorders
1.3.3 Liver Diseases
1.3.4 Gallstones
1.3.5 Other
1.4 Ursodeoxycholic Acid API Market by Grade
1.4.1 Global Ursodeoxycholic Acid API Market Value by Grade (2021-2032)
1.4.2 US Grade
1.4.3 EU Grade
1.4.4 Both
1.5 Ursodeoxycholic Acid API by Application
1.5.1 Global Ursodeoxycholic Acid API Market Value by Application (2021-2032)
1.5.2 Tablets
1.5.3 Capsules
1.5.4 Suspensions
1.6 Global Market Growth Prospects
1.6.1 Global Ursodeoxycholic Acid API Revenue (2021-2032)
1.6.2 Global Ursodeoxycholic Acid API Sales (2021-2032)
1.6.3 Global Ursodeoxycholic Acid API Market Average Price (2021-2032)
1.7 Assumptions and Limitations
1.8 Study Objectives
1.9 Years Considered
2 Key Insights
2.1 Key Emerging Trends
2.2 Key Developments – Mergers Acquisitions, New Product Launches, Collaborations, Partnerships and Joint Ventures
2.3 Latest Technological Advancements
2.4 Insights on Regulatory Scenarios
2.5 Porters Five Forces Analysis
3 Manufacturers Competitive Analysis
3.1 Global Ursodeoxycholic Acid API Revenue by Manufacturer (2021-2026)
3.2 Global Ursodeoxycholic Acid API Sales by Manufacturer (2021-2026)
3.3 Global Ursodeoxycholic Acid API Average Price by Manufacturer (2021-2026)
3.4 Ursodeoxycholic Acid API Company Evaluation Quadrant
3.5 Industry Rank
3.5.1 Global Key Players of Ursodeoxycholic Acid API, Industry Ranking, 2024 VS 2025
3.5.2 Global Ursodeoxycholic Acid API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5.3 Global Ursodeoxycholic Acid API Market Concentration Rate
3.5.4 Global 5 and 10 Largest Ursodeoxycholic Acid API Players Market Share by Revenue
3.6 Ursodeoxycholic Acid API Market: Overall Company Footprint Analysis
3.6.1 Ursodeoxycholic Acid API Market: Region Footprint
3.6.2 Ursodeoxycholic Acid API Market: Company Product Type Footprint
3.6.3 Ursodeoxycholic Acid API Market: Company Product Application Footprint
3.6.4 Global Key Manufacturers of Ursodeoxycholic Acid API, Date of Enter into This Industry
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
4 Manufacturers Profiles
4.1 ICE
4.1.1 ICE Ursodeoxycholic Acid API Details
4.1.2 ICE Ursodeoxycholic Acid API Product and Services
4.1.3 ICE Ursodeoxycholic Acid API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
4.1.4 ICE Major Business
4.1.5 ICE Recent Developments/Updates
4.2 Zhongshan Bailing
4.2.1 Zhongshan Bailing Ursodeoxycholic Acid API Details
4.2.2 Zhongshan Bailing Ursodeoxycholic Acid API Product and Services
4.2.3 Zhongshan Bailing Ursodeoxycholic Acid API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
4.2.4 Zhongshan Bailing Major Business
4.2.5 Zhongshan Bailing Recent Developments/Updates
4.3 Daewoong Chemical
4.3.1 Daewoong Chemical Ursodeoxycholic Acid API Details
4.3.2 Daewoong Chemical Ursodeoxycholic Acid API Product and Services
4.3.3 Daewoong Chemical Ursodeoxycholic Acid API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
4.3.4 Daewoong Chemical Major Business
4.3.5 Daewoong Chemical Recent Developments/Updates
4.4 PharmaZell GmbH
4.4.1 PharmaZell GmbH Ursodeoxycholic Acid API Details
4.4.2 PharmaZell GmbH Ursodeoxycholic Acid API Product and Services
4.4.3 PharmaZell GmbH Ursodeoxycholic Acid API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
4.4.4 PharmaZell GmbH Major Business
4.4.5 PharmaZell GmbH Recent Developments/Updates
4.5 Dipharma Francis
4.5.1 Dipharma Francis Ursodeoxycholic Acid API Details
4.5.2 Dipharma Francis Ursodeoxycholic Acid API Product and Services
4.5.3 Dipharma Francis Ursodeoxycholic Acid API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
4.5.4 Dipharma Francis Major Business
4.5.5 Dipharma Francis Recent Developments/Updates
4.6 Suzhou Tianlv
4.6.1 Suzhou Tianlv Ursodeoxycholic Acid API Details
4.6.2 Suzhou Tianlv Ursodeoxycholic Acid API Product and Services
4.6.3 Suzhou Tianlv Ursodeoxycholic Acid API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
4.6.4 Suzhou Tianlv Major Business
4.6.5 Suzhou Tianlv Recent Developments/Updates
4.7 Sichuan Xieli
4.7.1 Sichuan Xieli Ursodeoxycholic Acid API Details
4.7.2 Sichuan Xieli Ursodeoxycholic Acid API Product and Services
4.7.3 Sichuan Xieli Ursodeoxycholic Acid API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
4.7.4 Sichuan Xieli Major Business
4.7.5 Sichuan Xieli Recent Developments/Updates
4.8 Chuanning Bio
4.8.1 Chuanning Bio Ursodeoxycholic Acid API Details
4.8.2 Chuanning Bio Ursodeoxycholic Acid API Product and Services
4.8.3 Chuanning Bio Ursodeoxycholic Acid API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
4.8.4 Chuanning Bio Major Business
4.8.5 Chuanning Bio Recent Developments/Updates
4.9 Shilpa medicare
4.9.1 Shilpa medicare Ursodeoxycholic Acid API Details
4.9.2 Shilpa medicare Ursodeoxycholic Acid API Product and Services
4.9.3 Shilpa medicare Ursodeoxycholic Acid API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
4.9.4 Shilpa medicare Major Business
4.9.5 Shilpa medicare Recent Developments/Updates
4.10 Symbio generics
4.10.1 Symbio generics Ursodeoxycholic Acid API Details
4.10.2 Symbio generics Ursodeoxycholic Acid API Product and Services
4.10.3 Symbio generics Ursodeoxycholic Acid API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
4.10.4 Symbio generics Major Business
4.10.5 Symbio generics Recent Developments/Updates
4.11 Arch Pharma
4.11.1 Arch Pharma Ursodeoxycholic Acid API Details
4.11.2 Arch Pharma Ursodeoxycholic Acid API Product and Services
4.11.3 Arch Pharma Ursodeoxycholic Acid API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
4.11.4 Arch Pharma Major Business
4.11.5 Arch Pharma Recent Developments/Updates
5 Consumption Analysis by Region
5.1 Global Ursodeoxycholic Acid API Market Size by Region
5.1.1 Global Ursodeoxycholic Acid API Consumption Value by Region: 2021 VS 2025 VS 2032
5.1.2 Global Ursodeoxycholic Acid API Consumption Value by Region (2021-2026)
5.1.3 Global Ursodeoxycholic Acid API Consumption Value by Region (2027-2032)
5.1.4 Global Ursodeoxycholic Acid API Consumption Value Market Share by Region (2021-2032)
5.2 Global Ursodeoxycholic Acid API Sales Quantity by Region
5.2.1 Global Ursodeoxycholic Acid API Sales Quantity by Region: 2021 VS 2025 VS 2032
5.2.2 Global Ursodeoxycholic Acid API Sales Quantity by Region (2021-2026)
5.2.3 Global Ursodeoxycholic Acid API Sales Quantity by Region (2027-2032)
5.2.4 Global Ursodeoxycholic Acid API Sales Quantity Market Share by Region (2021-2032)
5.3 Global Ursodeoxycholic Acid API Average Price by Region
5.4 North America Ursodeoxycholic Acid API Consumption Value (2021-2032)
5.5 Europe Ursodeoxycholic Acid API Consumption Value (2021-2032)
5.6 Asia-Pacific Ursodeoxycholic Acid API Consumption Value (2021-2032)
5.7 South America Ursodeoxycholic Acid API Consumption Value (2021-2032)
5.8 Middle East & Africa Ursodeoxycholic Acid API Consumption Value (2021-2032)
6 Market Scenario by Region & Country
6.1 Global Ursodeoxycholic Acid API Consumption Value by Region & Country: 2021 VS 2025 VS 2032
6.2 Global Ursodeoxycholic Acid API Consumption Value by Region & Country (2021-2032)
6.3 Global Ursodeoxycholic Acid API Sales Quantity by Region & Country (2021-2032)
6.4 Global Ursodeoxycholic Acid API Average Price by Region & Country (2021-2032)
6.5 North America Ursodeoxycholic Acid API Market Facts & Figures by Country
6.5.1 North America Ursodeoxycholic Acid API Consumption Value by Country: 2021 VS 2025 VS 2032
6.5.2 North America Ursodeoxycholic Acid API Sales Quantity by Country (2021-2032)
6.5.3 North America Ursodeoxycholic Acid API Consumption Value by Country (2021-2032)
6.5.4 U.S.
6.5.5 Canada
6.6 Europe Ursodeoxycholic Acid API Market Facts & Figures by Country
6.6.1 Europe Ursodeoxycholic Acid API Consumption Value by Country: 2021 VS 2025 VS 2032
6.6.2 Europe Ursodeoxycholic Acid API Sales Quantity by Country (2021-2032)
6.6.3 Europe Ursodeoxycholic Acid API Consumption Value by Country (2021-2032)
6.6.4 Germany
6.6.5 France
6.6.6 U.K.
6.6.7 Italy
6.6.8 Russia
6.7 Asia Pacific Ursodeoxycholic Acid API Market Facts & Figures by Region
6.7.1 Asia Pacific Ursodeoxycholic Acid API Market Size by Region: 2021 VS 2025 VS 2032
6.7.2 Asia Pacific Ursodeoxycholic Acid API Sales Quantity by Region (2021-2032)
6.7.3 Asia Pacific Ursodeoxycholic Acid API Consumption Value by Region (2021-2032)
6.7.4 China
6.7.5 Japan
6.7.6 South Korea
6.7.7 India
6.7.8 Australia
6.7.9 Taiwan
6.7.10 Indonesia
6.7.11 Thailand
6.7.12 Malaysia
6.7.13 Philippines
6.8 South America Ursodeoxycholic Acid API Market Facts & Figures by Country
6.8.1 South America Ursodeoxycholic Acid API Market Size by Country: 2021 VS 2025 VS 2032
6.8.2 South America Ursodeoxycholic Acid API Sales Quantity by Country (2021-2032)
6.8.3 South America Ursodeoxycholic Acid API Consumption Value by Country
6.8.4 Mexico
6.8.5 Brazil
6.8.6 Argentina
6.9 Middle East and Africa Ursodeoxycholic Acid API Market Facts & Figures by Country
6.9.1 Middle East and Africa Ursodeoxycholic Acid API Market Size by Country: 2021 VS 2025 VS 2032
6.9.2 Middle East and Africa Ursodeoxycholic Acid API Sales Quantity by Country (2021-2032)
6.9.3 Middle East and Africa Ursodeoxycholic Acid API Consumption Value by Country
6.9.4 Turkey
6.9.5 Saudi Arabia
6.9.6 UAE
7 Segment by Type
7.1 Global Ursodeoxycholic Acid API Sales Quantity by Type (2021-2032)
7.1.1 Global Ursodeoxycholic Acid API Sales Quantity by Type (2021-2026)
7.1.2 Global Ursodeoxycholic Acid API Sales Quantity by Type (2027-2032)
7.1.3 Global Ursodeoxycholic Acid API Sales Quantity Market Share by Type (2021-2032)
7.2 Global Ursodeoxycholic Acid API Revenue by Type (2021-2032)
7.2.1 Global Ursodeoxycholic Acid API Revenue by Type (2021-2026)
7.2.2 Global Ursodeoxycholic Acid API Revenue by Type (2027-2032)
7.2.3 Global Ursodeoxycholic Acid API Revenue Market Share by Type (2021-2032)
7.3 Global Ursodeoxycholic Acid API Price by Type (2021-2032)
8 Segment by Application
8.1 Global Ursodeoxycholic Acid API Sales Quantity by Application (2021-2032)
8.1.1 Global Ursodeoxycholic Acid API Sales Quantity by Application (2021-2026)
8.1.2 Global Ursodeoxycholic Acid API Sales Quantity by Application (2027-2032)
8.1.3 Global Ursodeoxycholic Acid API Sales Quantity Market Share by Application (2021-2032)
8.2 Global Ursodeoxycholic Acid API Revenue by Application (2021-2032)
8.2.1 Global Ursodeoxycholic Acid API Revenue by Application (2021-2026)
8.2.2 Global Ursodeoxycholic Acid API Revenue by Application (2027-2032)
8.2.3 Global Ursodeoxycholic Acid API Revenue Market Share by Application (2021-2032)
8.3 Global Ursodeoxycholic Acid API Price by Application (2021-2032)
9 Industry Chain and Sales Channels Analysis
9.1 Ursodeoxycholic Acid API Industry Chain Analysis
9.2 Ursodeoxycholic Acid API Key Raw Materials
9.2.1 Key Raw Materials
9.2.2 Raw Materials Key Suppliers
9.3 Ursodeoxycholic Acid API Production Mode & Process
9.4 Ursodeoxycholic Acid API Sales and Marketing
9.4.1 Ursodeoxycholic Acid API Sales Channels
9.4.2 Ursodeoxycholic Acid API Distributors
9.5 Ursodeoxycholic Acid API Customers
10 Research Findings and Conclusion
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Author Details
11.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Ursodeoxycholic Acid API market is projected to grow from US$ 620 million in 2025 to US$ 1112 million by 2032, at a CAGR of 8.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-08
Pages: 161
USD 4900.00
(Single User License)
The global Ursodeoxycholic Acid API market size was US$ 620 million in 2025 and is forecast to reach a readjusted size of US$ 1112 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published Date: 2026-03-08
Pages: 96
USD 4250.00
(Single User License)
The global Ursodeoxycholic Acid API market was valued at US$ 620 million in 2025 and is anticipated to reach US$ 1112 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 137
USD 2900.00
(Single User License)
The global market for Ursodeoxycholic Acid API was estimated to be worth US$ 620 million in 2025 and is projected to reach US$ 1112 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 121
USD 3950.00
(Single User License)
The global Ursodeoxycholic Acid API market is projected to grow from US$ 583 million in 2024 to US$ 995 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 162
USD 4900.00
(Single User License)
The global market for Ursodeoxycholic Acid API was estimated to be worth US$ 583 million in 2024 and is forecast to a readjusted size of US$ 995 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-08-08
Pages: 119
USD 3950.00
(Single User License)
The global Ursodeoxycholic Acid API market size was US$ 583 million in 2024 and is forecast to a readjusted size of US$ 995 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-08-08
Pages: 96
USD 4250.00
(Single User License)
The global market for Ursodeoxycholic Acid API was valued at US$ 583 million in the year 2024 and is projected to reach a revised size of US$ 995 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published Date: 2025-08-08
Pages: 98
USD 2900.00
(Single User License)
The global Ursodeoxycholic Acid API market is projected to grow from US$ 609 million in 2025 to US$ 1006 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period.
Published Date: 2025-06-04
Pages: 160
USD 4900.00
(Single User License)
In 2024, the global market size of Ursodeoxycholic Acid API was estimated to be worth US$ 597 million and is forecast to reach approximately US$ 1091 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 137
USD 5900.00
(Single User License)
The global Ursodeoxycholic Acid API market is projected to grow from US$ 620 million in 2025 to US$ 1112 million by 2032, at a CAGR of 8.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-08
Pages: 161
The global Ursodeoxycholic Acid API market size was US$ 620 million in 2025 and is forecast to reach a readjusted size of US$ 1112 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published: 2026-03-08
Pages: 96
The global Ursodeoxycholic Acid API market was valued at US$ 620 million in 2025 and is anticipated to reach US$ 1112 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-03-08
Pages: 137
The global market for Ursodeoxycholic Acid API was estimated to be worth US$ 620 million in 2025 and is projected to reach US$ 1112 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-03-08
Pages: 121
The global Ursodeoxycholic Acid API market is projected to grow from US$ 583 million in 2024 to US$ 995 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 162
The global market for Ursodeoxycholic Acid API was estimated to be worth US$ 583 million in 2024 and is forecast to a readjusted size of US$ 995 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-08-08
Pages: 119
The global Ursodeoxycholic Acid API market size was US$ 583 million in 2024 and is forecast to a readjusted size of US$ 995 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-08-08
Pages: 96
The global market for Ursodeoxycholic Acid API was valued at US$ 583 million in the year 2024 and is projected to reach a revised size of US$ 995 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published: 2025-08-08
Pages: 98
The global Ursodeoxycholic Acid API market is projected to grow from US$ 609 million in 2025 to US$ 1006 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period.
Published: 2025-06-04
Pages: 160
In 2024, the global market size of Ursodeoxycholic Acid API was estimated to be worth US$ 597 million and is forecast to reach approximately US$ 1091 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 137
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now